| B-Type Natriuretic Peptide (BNP) Testing LCD-L33573 | Go to Site |
| B-Type Natriuretic Peptide (BNP) Billing and Coding A56826 | Go to Site |
| Biomarker Testing (Prior to Initial Biopsy) for Prostate Cancer Diagnosis: Billing and Coding -A56609 | Go to Site |
| NCD 190.1 Histocompatibility | Go to Site |
| Histocompatibility Testing: Billing and Coding | Download PDF |
| NCD 190.12 - Urine Culture, Bacteria | Download PDF |
| NCD 190.13 - Human Immunodeficiency Virus (HIV)Testing | Download PDF |
| NCD 190.14 - Human Immunodeficiency Virus (HIV) Testing (Diagnosis) | Download PDF |
| NCD 190.15 - Blood Counts | Download PDF |
| NCD 190.16 - Partial Thromboplastin Time (PTT) | Download PDF |
| NCD 190.17 - Prothrombin Time (PT) | Download PDF |
| NCD 190.18 - Serum Iron Studies | Download PDF |
| NCD 190.19 - Collagen Crosslinks, Any Method | Download PDF |
| NCD 190.2 - Diagnostic Pap Smears | Go to Site |
| NCD 190.20 - Blood Glucose Testing | Download PDF |
| NCD 190.21 - Glycated Hemoglobin Glycated Protein | Download PDF |
| NCD 190.22 - Thyroid Testing | Download PDF |
| NCD 190.23 - Lipids Testing | Download PDF |
| NCD 190.24 - Digoxin Therapeutic Drug Assay | Download PDF |
| NCD 190.25 - Alpha-fetoprotein | Download PDF |
| NCD 190.26 - Carcinoembryonic Antigen | Download PDF |
| NCD 190.27 - Human Chorionic Gonadotropin | Download PDF |
| NCD 190.28 - Tumor Antigen by Immunoassay CA 125 | Download PDF |
| NCD 190.29 - Tumor Antigen by Immunoassay CA 15-3 CA 27.29 | Download PDF |
| NCD 190.3 - Cytogenetic Studies | Go to Site |
| Billing and Coding: Cytogenetic Studies | Download PDF |
| NCD 190.30 - Tumor Antigen by Immunoassay CA 19-9 | Download PDF |
| NCD 190.31 - Prostate Specific Antigen | Download PDF |
| NCD 190.32 - Gamma Glutamyl Transferase | Download PDF |
| NCD 190.33 - Hepatitis Panel Acute Hepatitis Panel | Download PDF |
| NCD 190.34 - Fecal Occult Blood Test | Download PDF |
| NCD 190.5 - Sweat Testing | Go to Site |
| Sweat Testing: Billing and Coding | Download PDF |
| Genomic Sequence Analysis in the Treatment of Hematolymphoid Diseases: Billing and Coding LCD-L37606 | Go to Site |
| Genomic Sequence Analysis in the Treatment of Hematolymphoid Diseases A56793 | Go to Site |
| Genomic Sequence Analysis Solid Tumor Neoplasm LCD-L37810 | Go to Site |
| Genomic Sequence Analysis Panels in the Treatment of Solid Organ Neoplasms LCD-37810 | Go to Site |
| Genomic Sequence Analysis Panels in the Treatment of Solid Organ Neoplasms: Billing and Coding A56867 | Go to Site |
| Heavy Metal Testing LCD - L35074 | Go to Site |
| Heavy Metal Screening Billing and Coding A56767 | Go to Site |
| Mass Spectrometry (MS) Testing in Monoclonal Gammopathy (MG) LCD-L39189 | Go to Site |
| Mass Spectrometry (MS) Testing in Monoclonal Gammopathy (MG): Billing and Coding A58921 | Go to Site |
Molecular Pathology Procedures LCD-35000 Commercial payers might require preauthorization for Molecular Pathology tests | Go to Site |
| Molecular Pathology Procedures: Billing and Coding - A56199 | Go to Site |
| Multiplex Gastrointestinal Pathogen Panel (GPP) Tests for Acute Gastroenteritis (AGE) | Go to Site |
| Pharmacogenomic Testing (LCD L39995) | Go to Site |
| Pharmacogenomic Testing (A59915) Billing and Coding | Go to Site |
| RAST Type Tests LCD-L33591 | Go to Site |
| RAST Type Tests Billing and Coding A56844 | Go to Site |
| Respiratory Pathogen Panel Testing L39027 | Go to Site |
| Respiratory Pathogen Panel Testing: Billing and Coding A58741 | Go to Site |
| Urine Drug Testing LCD-L36037 | Go to Site |
| Urine Drug Testing Billing and Coding A59416 | Go to Site |
| Vitamin D Assay LCD-L37535 | Go to Site |
| Vitamin D Billing and Coding A57736 | Go to Site |